Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like Maternal PFAS levels can predict children’s brain structural and functional outcomes October 13, 2025 APOE gene variants influence metabolic patterns linked to aging and Alzheimer’s risk June 12, 2025 Flu viruses can use a second entry pathway to infect cells July 18, 2024
Maternal PFAS levels can predict children’s brain structural and functional outcomes October 13, 2025